Prices are updated after-hours
Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2022 - 10 - 26    source : Nutriband.com    save search
Nutriband Subsidiary, 4P Therapeutics LLC, Conducts Phase 1b Clinical Study for Sorrento Therapeutics, Inc. on Lymphatic Etanercept Delivery in Rheumatoid Arthritis Patients With Results To Be Presented at the 2022 American College of Rheumatology Conference
Published: 2022-10-26 (Crawled : 12:00) - nutriband.com
NTRB | $3.91 -3.22% -3.32% 26K twitter stocktwits trandingview |
Manufacturing
 | | O: 0.24% H: 10.71% C: -0.95%
SRNE | $0.024 -8.85% 57K twitter stocktwits trandingview |
Health Technology
 | | O: -3.14% H: 10.39% C: 3.25%
conference therapeutics study phase 2b
Gainers vs Losers
67% 33%

Top 10 Gainers
Your saved searches
Save your searches and get alerts when important news are released.